Loading…

NeoKor has commissioned a production facility in Kemerovo, Russia, for heart valve bioprostheses and other cardiovascular medical devices. Total investment was 346 million roubles, with capacity to produce 4,500 units per year, up from 2,000.
“NeoKor has commissioned a production facility in Kemerovo specialising in heart valve bioprostheses and other medical devices for cardiovascular surgery.”gxpnews.net
Summarized from public sources; check the original articles before acting on it.